391 related articles for article (PubMed ID: 33948352)
21. Regorafenib-Attenuated, Bleomycin-Induced Pulmonary Fibrosis by Inhibiting the TGF-β1 Signaling Pathway.
Li X; Ma L; Huang K; Wei Y; Long S; Liu Q; Zhang D; Wu S; Wang W; Yang G; Zhou H; Yang C
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671452
[TBL] [Abstract][Full Text] [Related]
22. Activation of p53-p21 is closely associated with the acquisition of resistance to apoptosis caused by β1-integrin silencing in head and neck cancer cells.
Kim MR; Chang HW; Nam HY; Han MW; Moon SY; Kim HJ; Lee HJ; Roh JL; Kim SW; Kim SY
Biochem Biophys Res Commun; 2012 Feb; 418(2):260-6. PubMed ID: 22266309
[TBL] [Abstract][Full Text] [Related]
23. Transforming growth factor (TGF) β1 acted through miR-130b to increase integrin α5 to promote migration of colorectal cancer cells.
Yi R; Li Y; Wang F; Gu J; Isaji T; Li J; Qi R; Zhu X; Zhao Y
Tumour Biol; 2016 Aug; 37(8):10763-73. PubMed ID: 26873488
[TBL] [Abstract][Full Text] [Related]
24. The impact of the particle size of curcumin nanocarriers and the ethanol on beta_1-integrin overexpression in fibroblasts: A regenerative pharmaceutical approach in skin repair and anti-aging formulations.
Tavakol S; Zare S; Hoveizi E; Tavakol B; Rezayat SM
Daru; 2019 Jun; 27(1):159-168. PubMed ID: 30875026
[TBL] [Abstract][Full Text] [Related]
25. Biocompatible and colloidally stabilized mPEG-PE/calcium phosphate hybrid nanoparticles loaded with siRNAs targeting tumors.
Gao P; Zhang X; Wang H; Zhang Q; Li H; Li Y; Duan Y
Oncotarget; 2016 Jan; 7(3):2855-66. PubMed ID: 26625203
[TBL] [Abstract][Full Text] [Related]
26. EGFR and β1-integrin targeting differentially affect colorectal carcinoma cell radiosensitivity and invasion.
Poschau M; Dickreuter E; Singh-Müller J; Zscheppang K; Eke I; Liersch T; Cordes N
Radiother Oncol; 2015 Sep; 116(3):510-6. PubMed ID: 26096850
[TBL] [Abstract][Full Text] [Related]
27. Regorafenib activates oxidative stress by inhibiting SELENOS and potentiates oxaliplatin-induced cell death in colon cancer cells.
Yu Y; Wu T; Zhang X; Li P; Ye L; Kuang J; Tao L; Ni L; Zhao Q; Zhang J; Pan H; Xie C; Zheng C; Li S; Cui R
Eur J Pharmacol; 2023 Oct; 957():175986. PubMed ID: 37598924
[TBL] [Abstract][Full Text] [Related]
28. Role of integrin-linked kinase in regulating phosphorylation of Akt and fibroblast survival in type I collagen matrices through a beta1 integrin viability signaling pathway.
Nho RS; Xia H; Kahm J; Kleidon J; Diebold D; Henke CA
J Biol Chem; 2005 Jul; 280(28):26630-9. PubMed ID: 15905178
[TBL] [Abstract][Full Text] [Related]
29. Regorafenib inhibits growth, angiogenesis, and metastasis in a highly aggressive, orthotopic colon cancer model.
Abou-Elkacem L; Arns S; Brix G; Gremse F; Zopf D; Kiessling F; Lederle W
Mol Cancer Ther; 2013 Jul; 12(7):1322-31. PubMed ID: 23619301
[TBL] [Abstract][Full Text] [Related]
30. Regorafenib: a novel multitargeted tyrosine kinase inhibitor for colorectal cancer and gastrointestinal stromal tumors.
Crona DJ; Keisler MD; Walko CM
Ann Pharmacother; 2013 Dec; 47(12):1685-96. PubMed ID: 24259629
[TBL] [Abstract][Full Text] [Related]
31. Regorafenib in combination with silybin as a novel potential strategy for the treatment of metastatic colorectal cancer.
Belli V; Sforza V; Cardone C; Martinelli E; Barra G; Matrone N; Napolitano S; Morgillo F; Tuccillo C; Federico A; Dallio M; Loguercio C; Gravina AG; De Palma R; Ciardiello F; Troiani T
Oncotarget; 2017 Sep; 8(40):68305-68316. PubMed ID: 28978118
[TBL] [Abstract][Full Text] [Related]
32. Integrin β1 mediates 5-fluorouracil chemoresistance under translational control of eIF4E in colorectal cancer.
Niu Z; Xu P; Zhu D; Tang W; Ji M; Lin Q; Liu T; Ren L; Wei Y; Xu J
Int J Clin Exp Pathol; 2018; 11(10):4771-4783. PubMed ID: 31949552
[TBL] [Abstract][Full Text] [Related]
33. A positive feedback loop of β-catenin/CCR2 axis promotes regorafenib resistance in colorectal cancer.
Ou B; Cheng X; Xu Z; Chen C; Shen X; Zhao J; Lu A
Cell Death Dis; 2019 Sep; 10(9):643. PubMed ID: 31501414
[TBL] [Abstract][Full Text] [Related]
34. PD-L1 Expression on Circulating Tumour Cells May Be Predictive of Response to Regorafenib in Patients Diagnosed with Chemorefractory Metastatic Colorectal Cancer.
Raimondi L; Raimondi FM; Di Benedetto L; Cimino G; Spinelli GP
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32962309
[TBL] [Abstract][Full Text] [Related]
35. T-DM1-resistant cells gain high invasive activity via EGFR and integrin cooperated pathways.
Endo Y; Shen Y; Youssef LA; Mohan N; Wu WJ
MAbs; 2018 Oct; 10(7):1003-1017. PubMed ID: 30130447
[TBL] [Abstract][Full Text] [Related]
36. Integrin alpha5/beta1 expression mediates HER-2 down-regulation in colon cancer cells.
Kuwada SK; Kuang J; Li X
J Biol Chem; 2005 May; 280(19):19027-35. PubMed ID: 15757908
[TBL] [Abstract][Full Text] [Related]
37. A polypeptide based podophyllotoxin conjugate for the treatment of multi drug resistant breast cancer with enhanced efficiency and minimal toxicity.
Zhou H; Lv S; Zhang D; Deng M; Zhang X; Tang Z; Chen X
Acta Biomater; 2018 Jun; 73():388-399. PubMed ID: 29694920
[TBL] [Abstract][Full Text] [Related]
38. Fine tuning micellar core-forming block of poly(ethylene glycol)-block-poly(ε-caprolactone) amphiphilic copolymers based on chemical modification for the solubilization and delivery of doxorubicin.
Yan J; Ye Z; Chen M; Liu Z; Xiao Y; Zhang Y; Zhou Y; Tan W; Lang M
Biomacromolecules; 2011 Jul; 12(7):2562-72. PubMed ID: 21598958
[TBL] [Abstract][Full Text] [Related]
39. The Impact of Primary Tumor Sidedness on the Effect of Regorafenib in Refractory Metastatic Colorectal Cancer.
Yoon SE; Lee SJ; Lee J; Park SH; Park JO; Lim HY; Kang WK; Park YS; Kim ST
J Cancer; 2019; 10(7):1611-1615. PubMed ID: 31205516
[TBL] [Abstract][Full Text] [Related]
40. Linsitinib and aspirin as the IGF1-R antagonists, inhibit regorafenib-resistant chemotherapy in colon cancer.
Guo Y; Mehrabi Nasab E; Hassanpour F; Athari SS
Saudi J Biol Sci; 2022 Feb; 29(2):872-877. PubMed ID: 35197754
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
